[throwingerman]

Wow this article is pretty condescending towards the biotech scene in Europe...

I'm going to go out on a limb here and say, maybe there are fewer biotech startups in Europe because profiting off of people's illnesses is generally frowned upon?

My guess is progress in that area falls more into the realm of government grants, with maybe the exception of classical pharmaceuticals (there are plenty of old companies like Bayer).

Biotech is not my field so I'd be interested in hearing other people's opinions.

[jonwachob91]

You should go back and reread the entire article. This isn’t a US is better than the rest of the world post, it’s a Boston/SF are getting really good at the whole life science startup thing.

[throwingerman]

Sure, I'd see no problem highlighting how far they've come. Sharing success stories is important. Which is why I found it odd that they were making multiple condescending references to Europe such as (paraphrasing) "if you're not in Boston or SF you might as well be in Europe" where it's making it sound like Siberia...